You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • OP0253 The Early Infliximab Levels Monitoring Can Predict the Developement of Anti-Drug Antibodies in a Cohort of Rheumatoid Arthritis Patients Treated with Infliximab

Alerts

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Oral Presentations. Therapeutic drug monitoring
OP0253 The Early Infliximab Levels Monitoring Can Predict the Developement of Anti-Drug Antibodies in a Cohort of Rheumatoid Arthritis Patients Treated with Infliximab
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address